Clinical Trials Directory

Trials / Completed

CompletedNCT00005481

Epidemiology of Impaired Coagulant Balance in Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
National Heart, Lung, and Blood Institute (NHLBI) · NIH
Sex
Male
Age
100 Years
Healthy volunteers
Not accepted

Summary

To determine the nature, extent and molecular mechanisms responsible for impaired fibrinolysis in White, Black, Hispanic and American Indian populations with respect to the presence or absence of diabetes. The overall objective is to determine whether impairments of fibrinolysis underlie subclinical and clinical vascular disease in diabetes in specific populations with and without accelerated microvascular disease.

Detailed description

BACKGROUND: The results of this project should clarify the extent to which results obtained in experimental animals pertain directly to diabetes in human subjects. The study will also assist in the interpretation of results from clinical studies and from platelet activation experiments. The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.

Conditions

Timeline

Start date
1996-09-01
Completion
2002-07-01
First posted
2000-05-26
Last updated
2016-05-13

Source: ClinicalTrials.gov record NCT00005481. Inclusion in this directory is not an endorsement.

Epidemiology of Impaired Coagulant Balance in Diabetes (NCT00005481) · Clinical Trials Directory